Miracle Mile Advisors’s Niagen Bioscience NAGE Stock Holding History

Miracle Mile Advisors’s Portfolio NAGE Stock Details NAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,000	Closed	-$69K	–	751
2025 Q1	$69K	Hold	10,000	–	–	﹤0.01%	636
2024 Q4	$53K	Hold	10,000	–	–	﹤0.01%	627
2024 Q3	$36.5K	Hold	10,000	–	–	﹤0.01%	520
2024 Q2	$27.3K	Buy	+10,000	New	+$33.5K	﹤0.01%	497
2021 Q4	–	Sell	-21,000	Closed	-$132K	–	486
2021 Q3	$132K	Buy	21,000 +2,000	+11%	+$16.5K	0.01%	408
2021 Q2	$187K	Hold	19,000	–	–	0.01%	365
2021 Q1	$177K	Sell	19,000 -1,000	-5%	-$7.93K	0.01%	361
2020 Q4	$96K	Sell	20,000 -11,000	-35%	-$53.6K	0.01%	361
2020 Q3	$124K	Sell	31,000 -10,000	-24%	-$48.2K	0.01%	342
2020 Q2	$188K	Sell	41,000 -25,000	-38%	-$112K	0.02%	290
2020 Q1	$215K	Hold	66,000	–	–	0.02%	252
2019 Q4	$284K	Buy	66,000 +6,000	+10%	+$21.3K	0.02%	246
2019 Q3	$236K	Sell	60,000 -5,000	-8%	-$21.3K	0.02%	254
2019 Q2	$302K	Hold	65,000	–	–	0.02%	219
2019 Q1	$272K	Buy	+65,000	New	+$234K	0.02%	225

Other funds holding NAGE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

TCM

Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Miracle Mile Advisors's NAGE Position: Q2 2025 in Review

Miracle Mile Advisors sold out of Niagen Bioscience (NAGE) in Q2 2025, closing a stake of 10,000 shares — an estimated $69K sold.

Miracle Mile Advisors first reported a position in NAGE in Q1 2019 and held it in 15 quarters. The position peaked at $302K in Q2 2019. 155 funds tracked by Wall St. Rank hold NAGE as of Q2 2025.

Miracle Mile Advisors reported no remaining Niagen Bioscience position as of Q2 2025 after selling out during the quarter.
Miracle Mile Advisors sold 10,000 Niagen Bioscience shares in Q2 2025, an estimated $69K.
Miracle Mile Advisors first reported a position in Niagen Bioscience in Q1 2019 and held it in 15 quarters.
Miracle Mile Advisors's Niagen Bioscience position peaked at $302K in Q2 2019.
155 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2025.

Based on Miracle Mile Advisors's 13F filing for Q2 2025, filed 22 Jul 2025.